Phase II trial assessing the efficacy of RECCE ® 327 topical gel (R327G) against acute bacterial skin and skin structure ...
Recce sees progression of Phase 2 study assessing efficacy of RECCE® 327 (R327G) topical gel against acute bacterial skin and ...
Approval allows for larger field treatment of actinic keratosis (AK) on face and scalp with Ameluz®-PDT using the BF-RhodoLED ...
Arthritis is a prevalent joint disease that impacts millions globally, causing pain, stiffness, and swelling in the affected joints. These symptoms can significantly diminish the quality of life.
We’ve rounded up the best, expert-recommended products to treat hyperpigmentation in dark skin, including cleansers, serums, ...
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application for Ameluz ® (aminolevulinic acid HCI) topical gel, 10% allowing for a larger field of treatment in patients ...
This approval allows healthcare professionals greater flexibility in addressing larger or multiple treatment areas for patients undergoing photodynamic therapy (PDT) for AK on the face and scalp ...
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application for Ameluz ® (aminolevulinic acid HCI) topical gel ... severity on the face and scalp.
Recce Pharmaceuticals Ltd (ASX:RCE) has reached the halfway mark in dosing participants in its Phase II Acute Bacterial Skin ...
In truth, we know what it is: those newly sprouted sunspots, hyperpigmentation, and melasma signs are often triggered by hot ...
This approval allows healthcare professionals greater flexibility in addressing larger or multiple treatment areas for patients undergoing photodynamic therapy (PDT) for AK on the face and scalp, ...